Mahony Susan
SEC insider (Form 3/4/5 filer). CIK 0001463321. Director at Axsome Therapeutics, Inc. (AXSM) and 2 other issuers. 12 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Mahony Susan has filed insider reports for
- Axsome Therapeutics, Inc. (AXSM): Director
- ASSEMBLY BIOSCIENCES, INC. (ASMB): Director
- Zymeworks Inc. (ZYME): Director
Mahony Susan
CIK: 0001463321
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jun 10, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect300 shares at avg. $246.18$74K - Jun 9, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect300 shares at avg. $237.21$71K - Jun 8, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect1.4K shares- - Jun 5, 2026AXSM
Axsome Therapeutics, Inc.
AwardDirectRestricted Stock Units
1.7K shares- - Jun 4, 2026ASMB
ASSEMBLY BIOSCIENCES, INC.
AwardDirectStock Option (right to buy)
8K shares- - Jan 12, 2026ZYME
Zymeworks Inc.
AwardDirectRestricted Stock Unit
7.7K shares- - Jan 12, 2026ZYME
Zymeworks Inc.
AwardDirectStock Option (Right to Buy)
11.5K shares- - Jun 6, 2025AXSM
Axsome Therapeutics, Inc.
AwardDirectRestricted Stock Units
1.4K shares- - Jun 6, 2025AXSM
Axsome Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
3.2K shares- - Jun 5, 2025ASMB
ASSEMBLY BIOSCIENCES, INC.
AwardDirectStock Option (right to buy)
3.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 |  AXSM Axsome Therapeutics, Inc. | Sale | 300 | $246.18 | $73,854 | Direct |
| Jun 9, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 300 | $237.21 | $71,163 | Direct |
| Jun 8, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 1,429 | - | $0 | Direct |
| Jun 5, 2026 | AXSM Axsome Therapeutics, Inc. | Award Restricted Stock Units | 1,721 | - | - | Direct |
| Jun 4, 2026 |  ASMB ASSEMBLY BIOSCIENCES, INC. | Award Stock Option (right to buy) | 8,000 | - | - | Direct |
| Jan 12, 2026 |  ZYME Zymeworks Inc. | Award Restricted Stock Unit | 7,700 | - | - | Direct |
| Jan 12, 2026 | ZYME Zymeworks Inc. | Award Stock Option (Right to Buy) | 11,500 | - | - | Direct |
| Jun 6, 2025 | AXSM Axsome Therapeutics, Inc. | Award Restricted Stock Units | 1,429 | - | - | Direct |
| Jun 6, 2025 | AXSM Axsome Therapeutics, Inc. | Award Stock Option (Right to Buy) | 3,166 | - | - | Direct |
| Jun 5, 2025 | ASMB ASSEMBLY BIOSCIENCES, INC. | Award Stock Option (right to buy) | 3,500 | - | - | Direct |
1-10 of 12 transactions